Wloters Kluwer Rx data show an increased Zubsolv tablets market share by 0.01 percentage points, now totaling 6.41 %. Four week average increased by 0.07 percentage points compared to previous week, now adding up to 6.29%. The 4-week rolling TRx average increased by 0.07 percentage points and now totaling 5.79%. The overall market for buprenorphine/naloxone products recorded 8.3% y/y growth (4-week average). TRx (4-week average) showed a y/y growth of 7.5%.